Both in Biotechnology
Metagenomi Therapeutics vs BioStem Technologies
Over the past year MGX returned −37.0% and BSEM returned −75.9%; their daily moves had a correlation of 0.18.
MGX −37.0% BSEM −75.9%Growth of $1, one year, split-adjusted
| Metric | MGX | BSEM |
|---|---|---|
| Price | $0.7308 | $1.04 |
| Market cap | $27.6M | $19.4M |
| Today | −7.49% | −9.57% |
| 1 month | −25.8% | −56.5% |
| 6 months | −48.5% | — |
| Year to date | −54.9% | — |
| 1 year | −68.1% | — |
| Revenue growth (YoY) | −103.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | — |
| Net cash | $120.7M | — |
| Dividend yield | — | — |
| Volatility (60d) | 49.8% | — |
| Short % of float | 5.2% | 2.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).